Yasumatsu, Ryuji
Shimizu, Yasushi
Hanai, Nobuhiro
Kariya, Shin
Yokota, Tomoya
Fujii, Takashi
Tsukahara, Kiyoaki
Ando, Mizuo
Hanyu, Kenji
Ueda, Tsutomu
Hirakawa, Hitoshi
Takahashi, Shunji
Ono, Takeharu
Sano, Daisuke
Yamauchi, Moriyasu
Watanabe, Akihito
Omori, Koichi
Yamazaki, Tomoko
Monden, Nobuya
Kudo, Naomi
Arai, Makoto
Yonekura, Syuji
Asakage, Takahiro
Nekado, Takahiro
Yamada, Takayuki
Homma, Akihiro http://orcid.org/0000-0003-1488-0646
Funding for this research was provided by:
Bristol-Myers Squibb K.K.
Ono Pharmaceutical Co., Ltd.
Article History
Received: 13 April 2021
Accepted: 30 September 2021
First Online: 13 November 2021
Declarations
:
: R. Yasumatsu reports grants from Ono Pharmaceutical Co., Ltd. during the conduct of the study. N. Hanai, K. Omori, and A. Homma report grants from Bristol-Myers Squibb K.K. and Ono Pharmaceutical Co., Ltd. during the conduct of the study. T. Yokota reports an advisory role for Merck Biopharma and personal fees from Bristol-Myers Squibb K.K, Merck Biopharma, and Ono Pharmaceutical Co., Ltd. during the conduct of the study. K. Tsukahara reports personal fees from Bristol-Myers Squibb K.K. and Ono Pharmaceutical Co., Ltd. during the conduct of the study. S. Takahashi reports grants and personal fees from AstraZeneca K.K., Bayer, Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., MSD, and Ono Pharmaceutical Co., Ltd. during the conduct of the study. T. Ueda reports a grant from Ono Pharmaceutical Co., Ltd. during the conduct of the study. T. Yamazaki reports grants from AstraZeneca K.K., Bristol-Myers Squibb K.K., and Ono Pharmaceutical Co., Ltd. during the conduct of the study. T. Yamada is an employee of Bristol-Myers Squibb K.K. T. Nekado is an employee of Ono Pharmaceutical Co., Ltd. Y. Shimizu, S. Kariya, T. Fujii, M. Ando, K. Hanyu, H. Hirakawa, T. Ono, D. Sano, M. Yamauchi, A. Watanabe, N. Monden, N. Kudo, M. Arai, S. Yonekura, T. Asakage, and M. Yoshida have nothing to disclose during the conduct of the study.